PETALING JAYA: Malaysia’s arsenal against Covid-19 has got a boost after Sinopharm and Johnson & Johnson vaccines were granted conditional approval for use in the national immunisation programme.
The Health Ministry said the Drug Control Authority (DCA) made the decision at a meeting yesterday.
